View Filing Data

Print Document View Excel Document

Document and Entity Information - shares shares in Millions	3 Months Ended
Document and Entity Information - shares shares in Millions	Dec. 29, 2018	Feb. 01, 2019
Document And Entity Information [Abstract]
Entity Registrant Name	BERRY GLOBAL GROUP INC
Entity Central Index Key	0001378992
Current Fiscal Year End Date	--09-28
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Ex Transition Period	false
Entity Common Stock, Shares Outstanding		130.3
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Dec. 29, 2018
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q1

Consolidated Statements of Income (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Dec. 29, 2018	Dec. 30, 2017
Consolidated Statements of Income (Unaudited) [Abstract]
Net sales	$ 1,972	$ 1,776
Costs and expenses:
Cost of goods sold	1,619	1,447
Selling, general and administrative	124	117
Amortization of intangibles	42	38
Restructuring and impairment charges	11	11
Operating income	176	163
Other (income) expense, net	0	9
Interest expense, net	64	62
Income before income taxes	112	92
Income tax expense (benefit)	24	(71)
Net income	$ 88	$ 163
Net income per share:
Basic (in dollars per share)	$ 0.67	$ 1.24
Diluted (in dollars per share)	$ 0.66	$ 1.20
Outstanding weighted-average shares:
Basic (in shares)	131.1	131.0
Diluted (in shares)	133.8	136.0

Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Dec. 29, 2018	Dec. 30, 2017
Consolidated Statements of Comprehensive Income (Unaudited) [Abstract]
Net income	$ 88	$ 163
Currency translation	(4)	(24)
Pension and other postretirement benefits	0	(1)
Interest rate hedges	(24)	17
Provision for income taxes	7	(4)
Other comprehensive loss, net of tax	(21)	(12)
Comprehensive income	$ 67	$ 151

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions	Dec. 29, 2018	Sep. 29, 2018
Current assets:
Cash and cash equivalents	$ 293	$ 381
Accounts receivable (less allowance of $13)	879	941
Inventories:
Finished goods	545	503
Raw materials and supplies	411	384
Inventories	956	887
Prepaid expenses and other current assets	78	76
Total current assets	2,206	2,285
Property, plant and equipment, net	2,457	2,488
Goodwill and intangible assets, net	4,243	4,284
Other assets	66	74
Total assets	8,972	9,131
Current liabilities:
Accounts payable	715	783
Accrued expenses and other current liabilities	427	416
Current portion of long-term debt	37	38
Total current liabilities	1,179	1,237
Long-term debt, less current portion	5,700	5,806
Deferred income taxes	357	365
Other long-term liabilities	281	289
Total liabilities	7,517	7,697
Stockholders' equity
Common stock (130.6 and 131.4 million shares issued, respectively)	1	1
Additional paid-in capital	873	867
Non-controlling interest	3	3
Retained earnings	755	719
Accumulated other comprehensive loss	(177)	(156)
Total stockholders' equity	1,455	1,434
Total liabilities and stockholders' equity	$ 8,972	$ 9,131

Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) shares in Millions, $ in Millions	Dec. 29, 2018	Sep. 29, 2018
Current assets:
Accounts receivable, allowance	$ 13	$ 13
Stockholders' equity
Common stock, shares issued (in shares)	130.6	131.4

Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($) $ in Millions	Common Stock [Member]	Additional Paid-in Capital [Member]	Non-Controlling Interest [Member]	Accumulated Other Comprehensive Loss [Member]	Retained Earnings [Member]	Total
Balance at Sep. 30, 2017	$ 1	$ 823	$ 3	$ (68)	$ 256	$ 1,015
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	0	4	0	0	0	4
Proceeds from issuance of common stock	0	4	0	0	0	4
Interest rate hedge, net of tax	0	0	0	13	0	13
Net income attributable to the Company	0	0	0	0	163	163
Currency translation	0	0	0	(24)	0	(24)
Pension	0	0	0	(1)	0	(1)
Balance at Dec. 30, 2017	1	831	3	(80)	419	1,174
Balance at Sep. 29, 2018	1	867	3	(156)	719	1,434
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	0	3	0	0	0	3
Proceeds from issuance of common stock	0	5	0	0	0	5
Common stock repurchased and retired	0	(2)	0	0	(52)	(54)
Interest rate hedge, net of tax	0	0	0	(17)	0	(17)
Net income attributable to the Company	0	0	0	0	88	88
Currency translation	0	0	0	(4)	0	(4)
Balance at Dec. 29, 2018	$ 1	$ 873	$ 3	$ (177)	$ 755	$ 1,455

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Dec. 29, 2018	Dec. 30, 2017
Cash Flows from Operating Activities:
Net income	$ 88	$ 163
Adjustments to reconcile net cash provided by operating activities:
Depreciation	96	91
Amortization of intangibles	42	38
Non-cash interest expense	(1)	3
Deferred income tax	4	(121)
Share-based compensation expense	3	4
Other non-cash operating activities, net	4	6
Changes in working capital	(71)	(66)
Changes in other assets and liabilities	(4)	35
Net cash from operating activities	161	153
Cash Flows from Investing Activities:
Additions to property, plant and equipment	(75)	(94)
Proceeds from sale of assets	0	3
Net cash from investing activities	(75)	(91)
Cash Flows from Financing Activities:
Repayments on long-term borrowings	(110)	(108)
Proceeds from issuance of common stock	5	4
Repurchase of common stock	(52)	0
Payment of tax receivable agreement	(16)	(37)
Net cash from financing activities	(173)	(141)
Effect of exchange rate changes on cash	(1)	1
Net change in cash	(88)	(78)
Cash and cash equivalents at beginning of period	381	306
Cash and cash equivalents at end of period	$ 293	$ 228

Basis of Presentation	3 Months Ended
Basis of Presentation	Dec. 29, 2018
Basis of Presentation [Abstract]
Basis of Presentation	1. Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements of Berry Global Group, Inc. ("the Company," "we," or "Berry") have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") pursuant to the rules and regulations of the Securities and Exchange Commission for interim reporting. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In preparing financial statements in conformity with GAAP, we must make estimates and assumptions that affect the reported amounts and disclosures at the date of the financial statements and during the reporting period. Actual results could differ from those estimates. Certain reclassifications have been made to prior periods to conform to current reporting. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included, and all subsequent events up to the time of the filing have been evaluated. For further information, refer to the Company's most recent Form 10-K filed with the Securities and Exchange Commission.

Recently Issued Accounting Pronouncements	3 Months Ended
Recently Issued Accounting Pronouncements	Dec. 29, 2018
Recently Issued Accounting Pronouncements [Abstract]
Recently Issued Accounting Pronouncements	2. Recently Issued Accounting Pronouncements Changes to GAAP are established by the Financial Accounting Standards Board ("FASB") in the form of accounting standards updates to the FASB's Accounting Standards Codification. During fiscal 2019, with the exception of the below, there have been no developments to the recently adopted accounting pronouncements from those disclosed in the Company's 2018 Annual Report on Form 10-K that are considered to have a material impact on our unaudited consolidated financial statements. Revenue Recognition In May 2014, the FASB issued a final standard on revenue recognition. Under the new standard, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. For public entities, the provisions of the new standard are effective for annual reporting periods beginning after December 15, 2017 and interim periods therein. An entity can apply the new revenue standard on a full retrospective approach to each prior reporting period presented or on a modified retrospective approach with the cumulative effect of initially applying the standard recognized at the date of initial application in retained earnings. The Company adopted the new standard effective for fiscal 2019 using the modified retrospective approach. The adoption of this standard did not have a material impact on the Company's consolidated financial statements. Leases In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which increases transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. Under the new standard, the lessee of an operating lease will be required to do the following: 1) recognize a right-of-use asset and a lease liability in the statement of financial position, 2) recognize a single lease cost allocated over the lease term generally on a straight-line basis, and 3) classify all cash payments within operating activities on the statement of cash flows. Companies are required to adopt this standard using a modified retrospective transition method. Amendments in this standard are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company is currently evaluating the impact of this standard, which will be effective for the Company beginning fiscal 2020.

Revenue Recognition	3 Months Ended
Revenue Recognition	Dec. 29, 2018
Revenue Recognition [Abstract]
Revenue Recognition	3. Revenue Recognition Our revenues are primarily derived from the sale of plastic packaging products to customers. Revenue is recognized when performance obligations are satisfied, in an amount reflecting the consideration the Company expects to be entitled. We consider the promise to transfer products to be our sole performance obligation. If the consideration agreed to in a contract includes a variable amount, we estimate the amount of consideration we expect to be entitled to in exchange for transferring the promised goods to the customer using the most likely amount method. Our main sources of variable consideration are customer rebates and cash discounts. There are no material instances where variable consideration is constrained and not recorded at the initial time of sale. Generally our revenue is recognized at a point in time for standard promised goods at the time of shipment, when title and risk of loss pass to the customer. A small number of our contracts are for sales of products which are customer specific and cannot be repurposed. Sales for these products qualify for over time recognition and are immaterial to the Company. Our rebate programs are individually negotiated with customers and contain a variety of different terms and conditions. Certain rebates are calculated as flat percentages of purchases, while others included tiered volume incentives. These rebates may be payable monthly, quarterly, or annually. The calculation of the accrued rebate balance involves management estimates, especially where the terms of the rebate involve tiered volume levels that require estimates of expected annual sales. These provisions are based on estimates derived from current program requirements and historical experience. The accrual for customer rebates was $64 million and $58 million at December 29, 2018 and September 29, 2018, respectively, and is included in Accrued expenses and other current liabilities. Due to the nature of our sales transactions, we have elected the following practical expedients: (i) Shipping and handling costs are treated as fulfillment costs. Accordingly, shipping and handling costs are classified as a component of Cost of goods sold while amounts billed to customers are classified as a component of Net Sales; (ii) We exclude sales and similar taxes that are imposed on our sales and collected from customers; (iii) As our standard payment terms are less than one year, we did not assess whether a contract has a significant financing component. The Company disaggregates revenue based on reportable business segment, geography, and significant product line. Refer to Note 11. Operating Segments for further information.

Acquisitions

3 Months Ended

Dec. 29, 2018

Acquisitions [Abstract]

Acquisitions

4. Acquisitions

Laddawn, Inc.

In August 2018, the Company acquired Laddawn, Inc. ("Laddawn") for a purchase price of $242 million, which is preliminary and subject to adjustment. Laddawn is a custom bag and film manufacturer with a unique-to-industry e-commerce sales platform. The acquired business is operated in our Engineered Materials segment. To finance the purchase, the Company used existing liquidity.

The acquisition has been accounted for under the purchase method of accounting and accordingly, the purchase price has been allocated to the identifiable assets and liabilities based on preliminary estimates of fair value at the acquisition date. The results of Laddawn have been included in the consolidated results of the Company since the date of the acquisition. The Company has not finalized the allocation of the purchase price to the fair value of the assets acquired and liabilities assumed. The assets acquired and liabilities assumed consisted of working capital of $26 million, property and equipment of $39 million, intangible assets of $98 million, and goodwill of $79 million. The working capital includes a $2 million step up of inventory to fair value. The Company has recognized goodwill on this transaction primarily as a result of expected cost synergies, and expects goodwill to be deductible for tax purposes.

Clopay Plastic Products Company, Inc.

In February 2018, the Company acquired Clopay Plastic Products Company, Inc. ("Clopay") for a purchase price of $475 million. Clopay is an innovator in the development of printed breathable films, elastic films, and laminates with product offerings uniquely designed for applications used in a number of markets including: hygiene, healthcare, construction and industrial protective apparel. The acquired business is operated within our Health, Hygiene & Specialties segment. To finance the purchase, the Company issued $500 million aggregate principal amount of 4.5% second priority notes through a private placement offering.

The acquisition has been accounted for under the purchase method of accounting, and accordingly, the purchase price has been allocated to the identifiable assets and liabilities based on fair values at the acquisition date. The results of Clopay have been included in the consolidated results of the Company since the date of the acquisition. The Company has recognized goodwill on this transaction primarily as a result of expected cost synergies, and expects goodwill to be deductible for tax purposes. The following table summarizes the purchase price allocation and estimated fair values of the assets acquired and liabilities assumed at the date of the acquisition:

Working capital (a)	$	70
Property and equipment		164
Intangible assets		125
Goodwill		111
Other assets and long-term liabilities		5

(a)

Includes a $3 million step up of inventory to fair value

Accounts Receivable Factoring Agreements	3 Months Ended
Accounts Receivable Factoring Agreements	Dec. 29, 2018
Accounts Receivable Factoring Agreements [Abstract]
Accounts Receivable Factoring Agreements	5. Accounts Receivable Factoring Agreements The Company has entered into various factoring agreements, both in the U.S. and at a number of foreign subsidiaries, to sell certain receivables to unrelated third-party financial institutions. The Company accounts for these transactions in accordance with ASC 860, "Transfers and Servicing" ("ASC 860"). ASC 860 allows for the ownership transfer of accounts receivable to qualify for sale treatment when the appropriate criteria is met, which permits the Company to present the balances sold under the program to be excluded from Accounts receivable, net on the Consolidated Balance Sheets. Receivables are considered sold when (i) they are transferred beyond the reach of the Company and its creditors, (ii) the purchaser has the right to pledge or exchange the receivables, and (iii) the Company has surrendered control over the transferred receivables. In addition, the Company provides no other forms of continued financial support to the purchaser of the receivables once the receivables are sold. There were no amounts outstanding from financial institutions related to U.S. based programs at December 29, 2018 or September 29, 2018. Gross amounts factored under these U.S. based programs at December 29, 2018 and September 29, 2018 were $212 million and $162 million, respectively. The fees associated with transfer of receivables for all programs were not material for any of the periods presented.

Restructuring and Impairment Charges

3 Months Ended

Dec. 29, 2018

Restructuring and Impairment Charges [Abstract]

Restructuring and Impairment Charges

6. Restructuring and Impairment Charges

The Company incurred restructuring costs of $11 million for both the quarterly period ended December 29, 2018 and December 30, 2017, respectively. The tables below set forth the significant components of the restructuring charges recognized, by segment:

	Quarterly Period Ended
	December 29, 2018		December 30, 2017
Consumer Packaging	$	—	$	1
Health, Hygiene & Specialties		10		10
Engineered Materials		1		—
Consolidated	$	11	$	11

The table below sets forth the activity with respect to the restructuring accrual at December 29, 2018:

	Employee Severance and Benefits			Facility Exit Costs			Non-cash Impairment Charges			Total
Balance at September 29, 2018	$	9			4			—		$	13
Charges		3			1			7			11
Non-cash asset impairment		—			—			(7	)		(7	)
Cash payments		(6	)		(1	)		—			(7	)
Balance at December 29, 2018	$	6			4			—		$	10

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities

3 Months Ended

Dec. 29, 2018

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities [Abstract]

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities

7. Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities

The following table sets forth the totals included in Accrued expenses and other current liabilities on the Consolidated Balance Sheets:

	December 29, 2018		September 29, 2018
Employee compensation	$	106	$	113
Accrued taxes		79		72
Rebates		64		58
Interest		43		49
Tax receivable agreement obligation		12		16
Restructuring		10		13
Accrued operating expenses		113		95
	$	427	$	416

The following table sets forth the totals included in Other long-term liabilities on the Consolidated Balance Sheets:

	December 29, 2018		September 29, 2018
Uncertain tax positions	$	68	$	67
Deferred purchase price		43		40
Pension liability		42		45
Lease retirement obligation		40		39
Sale-lease back deferred gain		21		21
Transition tax		18		18
Derivative instruments		13		12
Tax receivable agreement obligation		12		23
Other		24		24
	$	281	$	289

Long-Term Debt

3 Months Ended

Dec. 29, 2018

Long-Term Debt [Abstract]

Long-Term Debt

8. Long-Term Debt

Long-term debt consists of the following:

	Maturity Date	December 29, 2018			September 29, 2018
Term loan	February 2020	$	700		$	800
Term loan	January 2021		814			814
Term loan	October 2022		1,545			1,545
Term loan	January 2024		493			493
Revolving line of credit	May 2020		—			—
5 ¹/₂% Second Priority Senior Secured Notes	May 2022		500			500
6% Second Priority Senior Secured Notes	October 2022		400			400
5 ¹/₈% Second Priority Senior Secured Notes	July 2023		700			700
4 ¹/₂% Second Priority Senior Secured Notes	February 2026		500			500
Debt discounts and deferred fees			(40	)		(43	)
Capital leases and other	Various		125			135
Total long-term debt			5,737			5,844
Current portion of long-term debt			(37	)		(38	)
Long-term debt, less current portion		$	5,700		$	5,806

The Company was in compliance with all debt covenants for all periods presented.

Debt discounts and deferred financing fees are presented net of Long-term debt, less the current portion on the Consolidated Balance Sheets and are amortized to Interest expense through maturity.

Term Loans

The term loans with a maturity date of February 2020 and January 2021 bear interest at LIBOR plus 1.75%. The term loans with a maturity date of October 2022 and January 2024 bear interest at LIBOR plus 2.00%.

During fiscal 2019, the Company has made $110 million of repayments on long-term borrowings using existing liquidity.

Financial Instruments and Fair Value Measurements

3 Months Ended

Dec. 29, 2018

Financial Instruments and Fair Value Measurements [Abstract]

Financial Instruments and Fair Value Measurements

9. Financial Instruments and Fair Value Measurements

In the normal course of business, the Company is exposed to certain risks arising from business operations and economic factors. The Company may use derivative financial instruments to help manage market risk and reduce the exposure to fluctuations in interest rates and foreign currencies. These financial instruments are not used for trading or other speculative purposes. For those derivative instruments that are designated and qualify as hedging instruments, the Company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation.

To the extent hedging relationships are found to be effective, as determined by FASB guidance, changes in the fair value of the derivatives are offset by changes in the fair value of the related hedged item and recorded to Accumulated other comprehensive loss. Any identified ineffectiveness, or changes in the fair value of a derivative not designated as a hedge, is recorded to the Consolidated Statements of Income.

Cross-Currency Swaps

The Company is party to certain cross-currency swap agreements with a notional amount of 250 million euro to effectively convert a portion of our fixed-rate U.S. dollar denominated term loans, including the monthly interest payments, to fixed-rate euro-denominated debt. The swap agreements mature in May 2022. The risk management objective is to manage foreign currency risk relating to net investments in certain European subsidiaries denominated in foreign currencies and reduce the variability in the functional currency cash flows of a portion of the Company’s term loans. Changes in fair value of the derivative instruments are recognized in a component of Accumulated other comprehensive loss, to offset the changes in the values of the net investments being hedged.

Interest Rate Swaps

The primary purpose of the Company’s interest rate swap activities is to manage cash flow variability associated with our outstanding variable rate term loan debt.

During fiscal 2017 the Company modified various term loan rates and maturities. In conjunction with these modifications the Company realigned existing swap agreements which resulted in the de-designation of the original hedge and re-designation of the modified swaps as effective cash flow hedges. The amounts included in Accumulated other comprehensive loss at the date of de-designation are being amortized to Interest expense through the terms of the original swaps.

As of December 29, 2018, the Company effectively had (i) a $450 million interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 2.000%, with an effective date in May 2017 and expiration in May 2022 and (ii) a $1 billion interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 2.808% with an effective date in June 2018 and expiration in September 2021.

The Company records the fair value positions of all derivative financial instruments on a net basis by counterparty for which a master netting arrangement is utilized. Balances on a gross basis are as follows:

Derivatives Instruments

Hedge Designation

Balance Sheet Location

December 29, 2018

September 29, 2018

Cross-currency swaps

Designated

Other long-term liabilities

Interest rate swaps

Designated

Other assets

Interest rate swaps

Designated

Other long-term liabilities

—

Interest rate swaps

Not designated

Other long-term liabilities

—

The effect of the Company's derivative instruments on the Consolidated Statements of Income is as follows:

		Quarterly Period Ended
Derivatives instruments	Statement of Operations Location	December 29, 2018			December 30, 2017
Foreign currency swaps	Other (income) expense, net	$	(4	)	$	2
Interest rate swaps	Interest expense, net		(2	)		(1	)

The amortization related to unrealized losses in Accumulated other comprehensive loss is expected to be $9 million in the next 12 months.

Non-recurring Fair Value Measurements

The Company has certain assets that are measured at fair value on a non-recurring basis when impairment indicators are present or when the Company completes an acquisition. The Company adjusts certain long-lived assets to fair value only when the carrying values exceed the fair values. The categorization of the framework used to value the assets is considered Level 3, due to the subjective nature of the unobservable inputs used to determine the fair value. These assets that are subject to our annual impairment analysis primarily include our definite lived and indefinite lived intangible assets, including Goodwill and our property, plant and equipment. The Company reviews Goodwill and other indefinite lived assets for impairment as of the first day of the fourth fiscal quarter each year and more frequently if impairment indicators exist. The Company determined Goodwill and other indefinite lived assets were not impaired in our annual fiscal 2018 assessment. No impairment indicators were identified in the current quarter.

Included in the following table are the major categories of assets measured at fair value on a non-recurring basis as of December 29, 2018 and September 29, 2018, along with the impairment loss recognized on the fair value measurement during the period:

	As of December 29, 2018
	Level 1		Level 2		Level 3		Total		Impairment
Indefinite-lived trademarks	$	—	$	—	$	248	$	248	$	—
Goodwill		—		—		2,941		2,941		—
Definite lived intangible assets		—		—		1,054		1,054		—
Property, plant, and equipment		—		—		2,457		2,457		7
Total	$	—	$	—	$	6,700	$	6,700	$	7

	As of September 29, 2018
	Level 1		Level 2		Level 3		Total		Impairment
Indefinite-lived trademarks	$	—	$	—	$	248	$	248	$	—
Goodwill		—		—		2,944		2,944		—
Definite lived intangible assets		—		—		1,092		1,092		—
Property, plant, and equipment		—		—		2,488		2,488		—
Total	$	—	$	—	$	6,772	$	6,772	$	—

The Company's financial instruments consist primarily of cash and cash equivalents, long-term debt, interest rate and cross-currency swap agreements, and capital lease obligations. The book value of our long-term indebtedness exceeded fair value by $45 million as of December 29, 2018. The Company's long-term debt fair values were determined using Level 2 inputs as other significant observable inputs were not available.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Income Taxes	3 Months Ended
Income Taxes	Dec. 29, 2018
Income Taxes [Abstract]
Income Taxes	10. Income Taxes In December 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “Tax Act”). The transitional impacts of the Tax Act resulted in a transition benefit of $95 million in the quarterly period ended December 30, 2017. During the Quarter, the Company completed the accounting for the Tax Act, resulting in an immaterial change from fiscal 2018. The effective tax rate was 21% for the quarterly period ended December 29, 2018 and was positively impacted by 2% from the share-based compensation excess tax benefit deduction, 1% from research and development credits, and other discrete items. These favorable items were offset by increases of 4% from U.S. state income taxes and other discrete items.

Operating Segments

3 Months Ended

Dec. 29, 2018

Operating Segments [Abstract]

Operating Segments

11. Operating Segments

The Company's operations are organized into three operating segments: Engineered Materials, Health, Hygiene & Specialties, and Consumer Packaging. The structure is designed to align us with our customers, provide optimal service, and drive future growth in a cost efficient manner. Selected information by reportable segment is presented in the following tables:

	Quarterly Period Ended
	December 29, 2018		December 30, 2017
Net sales:
Engineered Materials	$	669	$	648
Health, Hygiene & Specialties		702		577
Consumer Packaging		601		551
Total net sales	$	1,972	$	1,776
Operating income:
Engineered Materials	$	94	$	88
Health, Hygiene & Specialties		49		37
Consumer Packaging		33		38
Total operating income	$	176	$	163
Depreciation and amortization:
Engineered Materials	$	31	$	29
Health, Hygiene & Specialties		54		46
Consumer Packaging		53		54
Total depreciation and amortization	$	138	$	129

	December 29, 2018		September 29, 2018
Total assets:
Engineered Materials	$	1,964	$	1,998
Health, Hygiene & Specialties		3,811		3,913
Consumer Packaging		3,197		3,220
Total assets	$	8,972	$	9,131

Total goodwill:
Engineered Materials	$	630	$	633
Health, Hygiene & Specialties		903		902
Consumer Packaging		1,408		1,409
Total goodwill	$	2,941	$	2,944

Selected information by geography is presented in the following tables:

	Quarterly Period Ended
	December 29, 2018		December 30, 2017
Net sales:
North America	$	1,605	$	1,466
South America		96		74
Europe		204		170
Asia		67		66
Total net sales	$	1,972	$	1,776

	December 29, 2018		September 29, 2018
Long-lived assets:
North America	$	5,685	$	5,764
South America		332		320
Europe		451		463
Asia		298		299
Total long-lived assets:	$	6,766	$	6,846

Selected information by product line is presented in the following tables:

	Quarterly Period Ended
	December 29, 2018			December 30, 2017
Net sales:
Performance Materials		39			43
Engineered Products		61			57
Engineered Materials		100	%		100	%

Health		18			19
Hygiene		52			44
Specialties		30			37
Health, Hygiene & Specialties		100	%		100	%

Rigid Open Top		44			43
Rigid Closed Top		56			57
Consumer Packaging		100	%		100	%

Contingencies and Commitments	3 Months Ended
Contingencies and Commitments	Dec. 29, 2018
Contingencies and Commitments [Abstract]
Contingencies and Commitments	12. Contingencies and Commitments The Company is party to various legal proceedings involving routine claims which are incidental to its business. Although the Company's legal and financial liability with respect to such proceedings cannot be estimated with certainty, management believes that any ultimate liability would not be material to its financial statements. The Company has various purchase commitments for raw materials, supplies, and property and equipment incidental to the ordinary conduct of business.

Share Repurchase Program	3 Months Ended
Share Repurchase Program	Dec. 29, 2018
Share Repurchase Program [Abstract]
Share Repurchase Program	13. Share Repurchase Program In fiscal 2018, the Company announced a $500 million share repurchase program. Berry may repurchase shares through the open market, privately negotiated transactions, or other programs, subject to market conditions. This authorization has no expiration date and may be suspended at any time. During the quarterly period ended December 29, 2018, the Company repurchased approximately 1,132 thousand shares for $54 million. As of December 29, 2018, $412 million of authorized share repurchases remain available to the Company.

Basic and Diluted Net Income Per Share

3 Months Ended

Dec. 29, 2018

Basic and Diluted Net Income Per Share [Abstract]

Basic and Diluted Net Income Per Share

14. Basic and Diluted Net Income Per Share

Basic net income per share is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common shares outstanding during the period, without consideration for common stock equivalents. Diluted net income per share is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common share equivalents outstanding for the period determined using the treasury-stock method and the if-converted method. For purposes of this calculation, stock options are considered to be common stock equivalents and are only included in the calculation of diluted net income per share when their effect is dilutive. For the three months ended December 29, 2018, 3 million shares were excluded from the diluted net income per share calculation as their effect would be anti-dilutive.

The following tables provide a reconciliation of the numerator and denominator of the basic and diluted net income per share calculations:

	Quarterly Period Ended
(in millions, except per share amounts)	December 29, 2018		December 30, 2017
Numerator
Consolidated net income	$	88	$	163
Denominator
Weighted average common shares outstanding - basic		131.1		131.0
Dilutive shares		2.7		5.0
Weighted average common and common equivalent shares outstanding - diluted		133.8		136.0

Per common share income
Basic	$	0.67	$	1.24
Diluted	$	0.66	$	1.20

Accumulated Other Comprehensive Loss

3 Months Ended

Dec. 29, 2018

Accumulated Other Comprehensive Loss [Abstract]

Accumulated Other Comprehensive Loss

15. Accumulated Other Comprehensive Loss

The components and activity of Accumulated other comprehensive loss are as follows:

	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps			Accumulated Other Comprehensive Loss
Balance at September 29, 2018	$	(175	)	$	(13	)	$	32		$	(156	)
Other comprehensive income (loss) before reclassifications		(4	)		—			(22	)		(26	)
Net amount reclassified from accumulated other comprehensive income (loss)		—			—			(2	)		(2	)
Provision for income taxes		—			—			7			7
Balance at December 29, 2018	$	(179	)	$	(13	)	$	15		$	(177	)

	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps			Accumulated Other Comprehensive Loss
Balance at September 30, 2017	$	(48	)	$	(16	)	$	(4	)	$	(68	)
Other comprehensive income (loss) before reclassifications		(24	)		(1	)		14			(11	)
Net amount reclassified from accumulated other comprehensive income (loss)		—			—			3			3
Provision for income taxes		—			—			(4	)		(4	)
Balance at December 30, 2017	$	(72	)	$	(17	)	$	9		$	(80	)

Guarantor and Non-Guarantor Financial Information

3 Months Ended

Dec. 29, 2018

Guarantor and Non-Guarantor Financial Information [Abstract]

Guarantor and Non-Guarantor Financial Information

16. Guarantor and Non-Guarantor Financial Information

Berry Global, Inc. (“Issuer”) has notes outstanding which are fully, jointly, severally, and unconditionally guaranteed by its parent, Berry Global Group, Inc. (for purposes of this Note, “Parent”) and substantially all of Issuer’s domestic subsidiaries. Separate narrative information or financial statements of the guarantor subsidiaries have not been included because they are 100% owned by Parent and the guarantor subsidiaries unconditionally guarantee such debt on a joint and several basis. A guarantee of a guarantor subsidiary of the securities will terminate upon the following customary circumstances: the sale of the capital stock of such guarantor if such sale complies with the indentures, the designation of such guarantor as an unrestricted subsidiary, the defeasance or discharge of the indenture or in the case of a restricted subsidiary that is required to guarantee after the relevant issuance date, if such guarantor no longer guarantees certain other indebtedness of the issuer. The guarantees of the guarantor subsidiaries are also limited as necessary to prevent them from constituting a fraudulent conveyance under applicable law and any guarantees guaranteeing subordinated debt are subordinated to certain other of the Company’s debts. Parent also guarantees the Issuer’s term loans and revolving credit facilities. The guarantor subsidiaries guarantee our term loans and are co-borrowers under our revolving credit facility. Presented below is condensed consolidating financial information for the Parent, Issuer, guarantor subsidiaries and non-guarantor subsidiaries. The Issuer and guarantor financial information includes all of our domestic operating subsidiaries; our non-guarantor subsidiaries include our foreign subsidiaries, certain immaterial domestic subsidiaries and the unrestricted subsidiaries under the Issuer’s indentures. The Parent uses the equity method to account for its ownership in the Issuer in the Condensed Consolidating Supplemental Financial Statements. The Issuer uses the equity method to account for its ownership in the guarantor and non-guarantor subsidiaries. All consolidating entries are included in the eliminations column along with the elimination of intercompany balances.

Condensed Supplemental Consolidated Statements of Income

	Quarterly Period Ended December 29, 2018
	Parent			Issuer			Guarantor Subsidiaries		Non-Guarantor Subsidiaries			Eliminations			Total
Net sales	$	—		$	141		$	1,377	$	454		$	—		$	1,972
Cost of goods sold		—			85			1,142		392			—			1,619
Selling, general and administrative		—			13			87		24			—			124
Amortization of intangibles		—			—			36		6			—			42
Restructuring and impairment charges		—			—			7		4			—			11
Operating income		—			43			105		28			—			176
Other expense (income), net		—			1			1		(2	)		—			—
Interest expense, net		—			5			45		14			—			64
Equity in net income of subsidiaries		(112	)		(67	)		—		—			179			—
Income before income taxes		112			104			59		16			(179	)		112
Income tax expense		24			16			—		8			(24	)		24
Net income	$	88		$	88		$	59	$	8		$	(155	)	$	88
Comprehensive net income	$	88		$	79		$	59	$	(4	)	$	(155	)	$	67

	Quarterly Period Ended December 30, 2017
	Parent			Issuer			Guarantor Subsidiaries		Non-Guarantor Subsidiaries			Eliminations			Total
Net sales	$	—		$	138		$	1,225	$	413		$	—		$	1,776
Cost of goods sold		—			106			989		352			—			1,447
Selling, general and administrative		—			12			80		25			—			117
Amortization of intangibles		—			—			31		7			—			38
Restructuring and impairment charges		—			—			7		4			—			11
Operating income (loss)		—			20			118		25			—			163
Other income, net		—			5			7		(3	)		—			9
Interest expense, net		—			5			43		14			—			62
Equity in net income of subsidiaries		(92	)		(72	)		—		—			164			—
Income before income taxes		92			82			68		14			(164	)		92
Income tax expense		(71	)		(81	)		—		10			71			(71	)
Net income	$	163		$	163		$	68	$	4		$	(235	)	$	163
Comprehensive net income	$	163		$	160		$	68	$	(5	)	$	(235	)	$	151

Condensed Supplemental Consolidated Balance Sheets

	December 29, 2018
	Parent		Issuer		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations			Total
Current assets		—		214		1,243		749		—			2,206
Intercompany receivable		248		1,878		—		28		(2,154	)		—
Property, plant, and equipment, net		—		79		1,660		718		—			2,457
Other assets		1,593		6,326		4,808		486		(8,904	)		4,309
Total assets	$	1,841	$	8,497	$	7,711	$	1,981	$	(11,058	)	$	8,972

Current liabilities		18		248		621		292		—			1,179
Intercompany payable		—		—		2,154		—		(2,154	)		—
Other long-term liabilities		368		5,851		58		61		—			6,338
Stockholders' equity		1,455		2,398		4,878		1,628		(8,904	)		1,455
Total liabilities and stockholders' equity	$	1,841	$	8,497	$	7,711	$	1,981	$	(11,058	)	$	8,972

	September 29, 2018
	Parent		Issuer		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations			Total
Current assets		—		249		1,240		796		—			2,285
Intercompany receivable		296		1,907		—		49		(2,252	)		—
Property, plant and equipment, net		—		79		1,684		725		—			2,488
Other assets		1,544		6,247		4,849		487		(8,769	)		4,358
Total assets	$	1,840	$	8,482	$	7,773	$	2,057	$	(11,021	)	$	9,131

Current liabilities		18		218		635		366		—			1,237
Intercompany payable		—		—		2,252		—		(2,252	)		—
Other long-term liabilities		388		5,945		68		59		—			6,460
Stockholders' equity		1,434		2,319		4,818		1,632		(8,769	)		1,434
Total liabilities and stockholders' equity	$	1,840	$	8,482	$	7,773	$	2,057	$	(11,021	)	$	9,131

Condensed Supplemental Consolidated Statements of Cash Flows

	Quarterly Period Ended December 29, 2018
	Parent			Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations			Total
Cash Flow from Operating Activities	$	—		$	55		$	155		$	(49	)	$	—		$	161
Cash Flow from Investing Activities
Additions to property, plant, and equipment		—			—			(59	)		(16	)		—			(75	)
Proceeds from sale of assets		—			—			—			—			—			—
(Contributions) distributions to/from subsidiaries		47			(47	)		—			—			—			—
Intercompany advances (repayments)		—			38			—			—			(38	)		—
Net cash from investing activities		47			(9	)		(59	)		(16	)		(38	)		(75	)

Cash Flow from Financing Activities
Repayments on long-term borrowings		—			(108	)		(2	)		—			—			(110	)
Proceeds from issuance of common stock		5			—			—			—			—			5
Repurchase of common stock		(52	)		—			—			—			—			(52	)
Payment of tax receivable agreement		(16	)		—			—			—			—			(16	)
Changes in intercompany balances		16			—			(93	)		39			38			—
Net cash from financing activities		(47	)		(108	)		(95	)		39			38			(173	)

Effect of exchange rate changes on cash		—			—			—			(1	)		—			(1	)

Net change in cash		—			(62	)		1			(27	)		—			(88	)
Cash and cash equivalents at beginning of period		—			133			4			244			—			381
Cash and cash equivalents at end of period	$	—		$	71		$	5		$	217		$	—		$	293

	Quarterly Period Ended December 30, 2017
	Parent			Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations			Total
Cash Flow from Operating Activities	$	—		$	35		$	139		$	(21	)	$	—		$	153
Cash Flow from Investing Activities
Additions to property, plant, and equipment		—			(3	)		(61	)		(30	)		—			(94	)
Proceeds from sale of assets		—			—			—			3			—			3
(Contributions) distributions to/from subsidiaries		(4	)		4			—			—			—			—
Intercompany advances (repayments)		—			69			—			—			(69	)		—
Other investing activities, net		—			—			—			—			—			—
Net cash from investing activities		(4	)		70			(61	)		(27	)		(69	)		(91	)

Cash Flow from Financing Activities
Repayments on long-term borrowings		—			(106	)		(2	)		—			—			(108	)
Proceeds from issuance of common stock		4			—			—			—			—			4
Payment of tax receivable agreement		(37	)		—			—			—			—			(37	)
Changes in intercompany balances		37			—			(86	)		(20	)		69			—
Net cash from financing activities		4			(106	)		(88	)		(20	)		69			(141	)

Effect of exchange rate changes on cash		—			—			—			1			—			1

Net change in cash		—			(1	)		(10	)		(67	)		—			(78	)
Cash and cash equivalents at beginning of period		—			18			12			276			—			306
Cash and cash equivalents at end of period	$	—		$	17		$	2		$	209		$	—		$	228

Basis of Presentation (Policies)	3 Months Ended
Basis of Presentation (Policies)	Dec. 29, 2018
Basis of Presentation [Abstract]
Basis of Presentation	The accompanying unaudited Condensed Consolidated Financial Statements of Berry Global Group, Inc. ("the Company," "we," or "Berry") have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") pursuant to the rules and regulations of the Securities and Exchange Commission for interim reporting. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.
Use of Estimates	In preparing financial statements in conformity with GAAP, we must make estimates and assumptions that affect the reported amounts and disclosures at the date of the financial statements and during the reporting period. Actual results could differ from those estimates.
Reclassifications	Certain reclassifications have been made to prior periods to conform to current reporting.

Recently Issued Accounting Pronouncements (Policies)	3 Months Ended
Recently Issued Accounting Pronouncements (Policies)	Dec. 29, 2018
Recently Issued Accounting Pronouncements [Abstract]
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements Changes to GAAP are established by the Financial Accounting Standards Board ("FASB") in the form of accounting standards updates to the FASB's Accounting Standards Codification. During fiscal 2019, with the exception of the below, there have been no developments to the recently adopted accounting pronouncements from those disclosed in the Company's 2018 Annual Report on Form 10-K that are considered to have a material impact on our unaudited consolidated financial statements. Revenue Recognition In May 2014, the FASB issued a final standard on revenue recognition. Under the new standard, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. For public entities, the provisions of the new standard are effective for annual reporting periods beginning after December 15, 2017 and interim periods therein. An entity can apply the new revenue standard on a full retrospective approach to each prior reporting period presented or on a modified retrospective approach with the cumulative effect of initially applying the standard recognized at the date of initial application in retained earnings. The Company adopted the new standard effective for fiscal 2019 using the modified retrospective approach. The adoption of this standard did not have a material impact on the Company's consolidated financial statements. Leases In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which increases transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. Under the new standard, the lessee of an operating lease will be required to do the following: 1) recognize a right-of-use asset and a lease liability in the statement of financial position, 2) recognize a single lease cost allocated over the lease term generally on a straight-line basis, and 3) classify all cash payments within operating activities on the statement of cash flows. Companies are required to adopt this standard using a modified retrospective transition method. Amendments in this standard are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company is currently evaluating the impact of this standard, which will be effective for the Company beginning fiscal 2020.

Acquisitions (Tables)

3 Months Ended

Dec. 29, 2018

Acquisitions [Abstract]

Purchase Price Allocation

The following table summarizes the purchase price allocation and estimated fair values of the assets acquired and liabilities assumed at the date of the acquisition:

Working capital (a)	$	70
Property and equipment		164
Intangible assets		125
Goodwill		111
Other assets and long-term liabilities		5

(a)

Includes a $3 million step up of inventory to fair value

Restructuring and Impairment Charges (Tables)

3 Months Ended

Dec. 29, 2018

Restructuring and Impairment Charges [Abstract]

Restructuring Charges by Segment

The tables below set forth the significant components of the restructuring charges recognized, by segment:

	Quarterly Period Ended
	December 29, 2018		December 30, 2017
Consumer Packaging	$	—	$	1
Health, Hygiene & Specialties		10		10
Engineered Materials		1		—
Consolidated	$	11	$	11

Restructuring Accrual Activity

The table below sets forth the activity with respect to the restructuring accrual at December 29, 2018:

	Employee Severance and Benefits			Facility Exit Costs			Non-cash Impairment Charges			Total
Balance at September 29, 2018	$	9			4			—		$	13
Charges		3			1			7			11
Non-cash asset impairment		—			—			(7	)		(7	)
Cash payments		(6	)		(1	)		—			(7	)
Balance at December 29, 2018	$	6			4			—		$	10

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities (Tables)

3 Months Ended

Dec. 29, 2018

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities [Abstract]

Accrued Expenses and Other Current Liabilities

The following table sets forth the totals included in Accrued expenses and other current liabilities on the Consolidated Balance Sheets:

	December 29, 2018		September 29, 2018
Employee compensation	$	106	$	113
Accrued taxes		79		72
Rebates		64		58
Interest		43		49
Tax receivable agreement obligation		12		16
Restructuring		10		13
Accrued operating expenses		113		95
	$	427	$	416

Other Long-Term Liabilities

The following table sets forth the totals included in Other long-term liabilities on the Consolidated Balance Sheets:

	December 29, 2018		September 29, 2018
Uncertain tax positions	$	68	$	67
Deferred purchase price		43		40
Pension liability		42		45
Lease retirement obligation		40		39
Sale-lease back deferred gain		21		21
Transition tax		18		18
Derivative instruments		13		12
Tax receivable agreement obligation		12		23
Other		24		24
	$	281	$	289

Long-Term Debt (Tables)

3 Months Ended

Dec. 29, 2018

Long-Term Debt [Abstract]

Long-Term Debt

Long-term debt consists of the following:

	Maturity Date	December 29, 2018			September 29, 2018
Term loan	February 2020	$	700		$	800
Term loan	January 2021		814			814
Term loan	October 2022		1,545			1,545
Term loan	January 2024		493			493
Revolving line of credit	May 2020		—			—
5 ¹/₂% Second Priority Senior Secured Notes	May 2022		500			500
6% Second Priority Senior Secured Notes	October 2022		400			400
5 ¹/₈% Second Priority Senior Secured Notes	July 2023		700			700
4 ¹/₂% Second Priority Senior Secured Notes	February 2026		500			500
Debt discounts and deferred fees			(40	)		(43	)
Capital leases and other	Various		125			135
Total long-term debt			5,737			5,844
Current portion of long-term debt			(37	)		(38	)
Long-term debt, less current portion		$	5,700		$	5,806

Financial Instruments and Fair Value Measurements (Tables)

3 Months Ended

Dec. 29, 2018

Financial Instruments and Fair Value Measurements [Abstract]

Fair Value of Derivatives and Location on Consolidated Balance Sheets

Derivatives Instruments

Hedge Designation

Balance Sheet Location

December 29, 2018

September 29, 2018

Cross-currency swaps

Designated

Other long-term liabilities

Interest rate swaps

Designated

Other assets

Interest rate swaps

Designated

Other long-term liabilities

—

Interest rate swaps

Not designated

Other long-term liabilities

—

Effect of Derivatives on Consolidated Statements of Income

The effect of the Company's derivative instruments on the Consolidated Statements of Income is as follows:

		Quarterly Period Ended
Derivatives instruments	Statement of Operations Location	December 29, 2018			December 30, 2017
Foreign currency swaps	Other (income) expense, net	$	(4	)	$	2
Interest rate swaps	Interest expense, net		(2	)		(1	)

Assets Measured at Fair Value on Non-recurring Basis

	As of December 29, 2018
	Level 1		Level 2		Level 3		Total		Impairment
Indefinite-lived trademarks	$	—	$	—	$	248	$	248	$	—
Goodwill		—		—		2,941		2,941		—
Definite lived intangible assets		—		—		1,054		1,054		—
Property, plant, and equipment		—		—		2,457		2,457		7
Total	$	—	$	—	$	6,700	$	6,700	$	7

	As of September 29, 2018
	Level 1		Level 2		Level 3		Total		Impairment
Indefinite-lived trademarks	$	—	$	—	$	248	$	248	$	—
Goodwill		—		—		2,944		2,944		—
Definite lived intangible assets		—		—		1,092		1,092		—
Property, plant, and equipment		—		—		2,488		2,488		—
Total	$	—	$	—	$	6,772	$	6,772	$	—

Operating Segments (Tables)

3 Months Ended

Dec. 29, 2018

Operating Segments [Abstract]

Selected Information by Reportable Segment

Selected information by reportable segment is presented in the following tables:

	Quarterly Period Ended
	December 29, 2018		December 30, 2017
Net sales:
Engineered Materials	$	669	$	648
Health, Hygiene & Specialties		702		577
Consumer Packaging		601		551
Total net sales	$	1,972	$	1,776
Operating income:
Engineered Materials	$	94	$	88
Health, Hygiene & Specialties		49		37
Consumer Packaging		33		38
Total operating income	$	176	$	163
Depreciation and amortization:
Engineered Materials	$	31	$	29
Health, Hygiene & Specialties		54		46
Consumer Packaging		53		54
Total depreciation and amortization	$	138	$	129

	December 29, 2018		September 29, 2018
Total assets:
Engineered Materials	$	1,964	$	1,998
Health, Hygiene & Specialties		3,811		3,913
Consumer Packaging		3,197		3,220
Total assets	$	8,972	$	9,131

Total goodwill:
Engineered Materials	$	630	$	633
Health, Hygiene & Specialties		903		902
Consumer Packaging		1,408		1,409
Total goodwill	$	2,941	$	2,944

Selected Information by Geography

Selected information by geography is presented in the following tables:

	Quarterly Period Ended
	December 29, 2018		December 30, 2017
Net sales:
North America	$	1,605	$	1,466
South America		96		74
Europe		204		170
Asia		67		66
Total net sales	$	1,972	$	1,776

	December 29, 2018		September 29, 2018
Long-lived assets:
North America	$	5,685	$	5,764
South America		332		320
Europe		451		463
Asia		298		299
Total long-lived assets:	$	6,766	$	6,846

Selected Information by Product Line

Selected information by product line is presented in the following tables:

	Quarterly Period Ended
	December 29, 2018			December 30, 2017
Net sales:
Performance Materials		39			43
Engineered Products		61			57
Engineered Materials		100	%		100	%

Health		18			19
Hygiene		52			44
Specialties		30			37
Health, Hygiene & Specialties		100	%		100	%

Rigid Open Top		44			43
Rigid Closed Top		56			57
Consumer Packaging		100	%		100	%

Basic and Diluted Net Income Per Share (Tables)

3 Months Ended

Dec. 29, 2018

Basic and Diluted Net Income Per Share [Abstract]

Basic and Diluted Net Income Per Share

The following tables provide a reconciliation of the numerator and denominator of the basic and diluted net income per share calculations:

	Quarterly Period Ended
(in millions, except per share amounts)	December 29, 2018		December 30, 2017
Numerator
Consolidated net income	$	88	$	163
Denominator
Weighted average common shares outstanding - basic		131.1		131.0
Dilutive shares		2.7		5.0
Weighted average common and common equivalent shares outstanding - diluted		133.8		136.0

Per common share income
Basic	$	0.67	$	1.24
Diluted	$	0.66	$	1.20

Accumulated Other Comprehensive Loss (Tables)

3 Months Ended

Dec. 29, 2018

Accumulated Other Comprehensive Loss [Abstract]

Accumulated Other Comprehensive Loss

The components and activity of Accumulated other comprehensive loss are as follows:

	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps			Accumulated Other Comprehensive Loss
Balance at September 29, 2018	$	(175	)	$	(13	)	$	32		$	(156	)
Other comprehensive income (loss) before reclassifications		(4	)		—			(22	)		(26	)
Net amount reclassified from accumulated other comprehensive income (loss)		—			—			(2	)		(2	)
Provision for income taxes		—			—			7			7
Balance at December 29, 2018	$	(179	)	$	(13	)	$	15		$	(177	)

	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps			Accumulated Other Comprehensive Loss
Balance at September 30, 2017	$	(48	)	$	(16	)	$	(4	)	$	(68	)
Other comprehensive income (loss) before reclassifications		(24	)		(1	)		14			(11	)
Net amount reclassified from accumulated other comprehensive income (loss)		—			—			3			3
Provision for income taxes		—			—			(4	)		(4	)
Balance at December 30, 2017	$	(72	)	$	(17	)	$	9		$	(80	)

Guarantor and Non-Guarantor Financial Information (Tables)

3 Months Ended

Dec. 29, 2018

Guarantor and Non-Guarantor Financial Information [Abstract]

Condensed Supplemental Consolidated Financial Information

Condensed Supplemental Consolidated Statements of Income

	Quarterly Period Ended December 29, 2018
	Parent			Issuer			Guarantor Subsidiaries		Non-Guarantor Subsidiaries			Eliminations			Total
Net sales	$	—		$	141		$	1,377	$	454		$	—		$	1,972
Cost of goods sold		—			85			1,142		392			—			1,619
Selling, general and administrative		—			13			87		24			—			124
Amortization of intangibles		—			—			36		6			—			42
Restructuring and impairment charges		—			—			7		4			—			11
Operating income		—			43			105		28			—			176
Other expense (income), net		—			1			1		(2	)		—			—
Interest expense, net		—			5			45		14			—			64
Equity in net income of subsidiaries		(112	)		(67	)		—		—			179			—
Income before income taxes		112			104			59		16			(179	)		112
Income tax expense		24			16			—		8			(24	)		24
Net income	$	88		$	88		$	59	$	8		$	(155	)	$	88
Comprehensive net income	$	88		$	79		$	59	$	(4	)	$	(155	)	$	67

	Quarterly Period Ended December 30, 2017
	Parent			Issuer			Guarantor Subsidiaries		Non-Guarantor Subsidiaries			Eliminations			Total
Net sales	$	—		$	138		$	1,225	$	413		$	—		$	1,776
Cost of goods sold		—			106			989		352			—			1,447
Selling, general and administrative		—			12			80		25			—			117
Amortization of intangibles		—			—			31		7			—			38
Restructuring and impairment charges		—			—			7		4			—			11
Operating income (loss)		—			20			118		25			—			163
Other income, net		—			5			7		(3	)		—			9
Interest expense, net		—			5			43		14			—			62
Equity in net income of subsidiaries		(92	)		(72	)		—		—			164			—
Income before income taxes		92			82			68		14			(164	)		92
Income tax expense		(71	)		(81	)		—		10			71			(71	)
Net income	$	163		$	163		$	68	$	4		$	(235	)	$	163
Comprehensive net income	$	163		$	160		$	68	$	(5	)	$	(235	)	$	151

Condensed Supplemental Consolidated Balance Sheets

	December 29, 2018
	Parent		Issuer		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations			Total
Current assets		—		214		1,243		749		—			2,206
Intercompany receivable		248		1,878		—		28		(2,154	)		—
Property, plant, and equipment, net		—		79		1,660		718		—			2,457
Other assets		1,593		6,326		4,808		486		(8,904	)		4,309
Total assets	$	1,841	$	8,497	$	7,711	$	1,981	$	(11,058	)	$	8,972

Current liabilities		18		248		621		292		—			1,179
Intercompany payable		—		—		2,154		—		(2,154	)		—
Other long-term liabilities		368		5,851		58		61		—			6,338
Stockholders' equity		1,455		2,398		4,878		1,628		(8,904	)		1,455
Total liabilities and stockholders' equity	$	1,841	$	8,497	$	7,711	$	1,981	$	(11,058	)	$	8,972

	September 29, 2018
	Parent		Issuer		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations			Total
Current assets		—		249		1,240		796		—			2,285
Intercompany receivable		296		1,907		—		49		(2,252	)		—
Property, plant and equipment, net		—		79		1,684		725		—			2,488
Other assets		1,544		6,247		4,849		487		(8,769	)		4,358
Total assets	$	1,840	$	8,482	$	7,773	$	2,057	$	(11,021	)	$	9,131

Current liabilities		18		218		635		366		—			1,237
Intercompany payable		—		—		2,252		—		(2,252	)		—
Other long-term liabilities		388		5,945		68		59		—			6,460
Stockholders' equity		1,434		2,319		4,818		1,632		(8,769	)		1,434
Total liabilities and stockholders' equity	$	1,840	$	8,482	$	7,773	$	2,057	$	(11,021	)	$	9,131

Condensed Supplemental Consolidated Statements of Cash Flows

	Quarterly Period Ended December 29, 2018
	Parent			Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations			Total
Cash Flow from Operating Activities	$	—		$	55		$	155		$	(49	)	$	—		$	161
Cash Flow from Investing Activities
Additions to property, plant, and equipment		—			—			(59	)		(16	)		—			(75	)
Proceeds from sale of assets		—			—			—			—			—			—
(Contributions) distributions to/from subsidiaries		47			(47	)		—			—			—			—
Intercompany advances (repayments)		—			38			—			—			(38	)		—
Net cash from investing activities		47			(9	)		(59	)		(16	)		(38	)		(75	)

Cash Flow from Financing Activities
Repayments on long-term borrowings		—			(108	)		(2	)		—			—			(110	)
Proceeds from issuance of common stock		5			—			—			—			—			5
Repurchase of common stock		(52	)		—			—			—			—			(52	)
Payment of tax receivable agreement		(16	)		—			—			—			—			(16	)
Changes in intercompany balances		16			—			(93	)		39			38			—
Net cash from financing activities		(47	)		(108	)		(95	)		39			38			(173	)

Effect of exchange rate changes on cash		—			—			—			(1	)		—			(1	)

Net change in cash		—			(62	)		1			(27	)		—			(88	)
Cash and cash equivalents at beginning of period		—			133			4			244			—			381
Cash and cash equivalents at end of period	$	—		$	71		$	5		$	217		$	—		$	293

	Quarterly Period Ended December 30, 2017
	Parent			Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations			Total
Cash Flow from Operating Activities	$	—		$	35		$	139		$	(21	)	$	—		$	153
Cash Flow from Investing Activities
Additions to property, plant, and equipment		—			(3	)		(61	)		(30	)		—			(94	)
Proceeds from sale of assets		—			—			—			3			—			3
(Contributions) distributions to/from subsidiaries		(4	)		4			—			—			—			—
Intercompany advances (repayments)		—			69			—			—			(69	)		—
Other investing activities, net		—			—			—			—			—			—
Net cash from investing activities		(4	)		70			(61	)		(27	)		(69	)		(91	)

Cash Flow from Financing Activities
Repayments on long-term borrowings		—			(106	)		(2	)		—			—			(108	)
Proceeds from issuance of common stock		4			—			—			—			—			4
Payment of tax receivable agreement		(37	)		—			—			—			—			(37	)
Changes in intercompany balances		37			—			(86	)		(20	)		69			—
Net cash from financing activities		4			(106	)		(88	)		(20	)		69			(141	)

Effect of exchange rate changes on cash		—			—			—			1			—			1

Net change in cash		—			(1	)		(10	)		(67	)		—			(78	)
Cash and cash equivalents at beginning of period		—			18			12			276			—			306
Cash and cash equivalents at end of period	$	—		$	17		$	2		$	209		$	—		$	228

Revenue Recognition (Details) - USD ($) $ in Millions	Dec. 29, 2018	Sep. 29, 2018
Revenue Recognition [Abstract]
Accrual for customer rebates	$ 64	$ 58

Acquisitions, Laddawn, Inc. (Details) - USD ($) $ in Millions	Aug. 31, 2018	Dec. 29, 2018	Sep. 29, 2018
Acquisitions [Abstract]
Goodwill		$ 2,941	$ 2,944
Laddawn [Member]
Acquisitions [Abstract]
Purchase price	$ 242
Working capital	26
Property and equipment	39
Intangible assets	98
Goodwill	79
Step up of inventory to fair value	$ 2

Acquisitions, Clopay Plastic Products Company, Inc. (Details) - USD ($)
$ in Millions

Feb. 28, 2018

Dec. 29, 2018

Sep. 29, 2018

Jan. 31, 2018

Allocation of Purchase Price [Abstract]

Goodwill

$ 2,941

$ 2,944

4.50% Second Priority Senior Secured Notes due 2026 [Member]

Acquisitions [Abstract]

Face amount of debt issued

$ 500

Interest rate

4.50%

Clopay [Member]

Acquisitions [Abstract]

Purchase price

$ 475

Allocation of Purchase Price [Abstract]

Working capital

^[1]

Property and equipment

164

Intangible assets

125

Goodwill

111

Other assets and long-term liabilities

Step up of inventory to fair value

$ 3

[1]	Includes a $3 million step up of inventory to fair value.

Accounts Receivable Factoring Agreements (Details) - USD ($) $ in Millions	Dec. 29, 2018	Sep. 29, 2018
Accounts Receivable Factoring Agreements [Abstract]
Amounts due from financial institutions	$ 0	$ 0
Trade receivables sold to financial institutions	$ 212	$ 162

Restructuring and Impairment Charges, Restructuring Charges by Segment (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 29, 2018	Dec. 30, 2017
Restructuring Charges [Abstract]
Restructuring charges	$ 11	$ 11
Consumer Packaging [Member]
Restructuring Charges [Abstract]
Restructuring charges	0	1
Health, Hygiene & Specialties [Member]
Restructuring Charges [Abstract]
Restructuring charges	10	10
Engineered Materials [Member]
Restructuring Charges [Abstract]
Restructuring charges	$ 1	$ 0

Restructuring and Impairment Charges, Restructuring Accrual Activity (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Dec. 29, 2018	Dec. 30, 2017	Sep. 29, 2018
Restructuring Accrual [Roll Forward]
Beginning balance	$ 13
Charges	11	$ 11
Non-cash asset impairment	(7)		$ 0
Cash payments	(7)
Ending balance	10		13
Employee Severance and Benefits [Member]
Restructuring Accrual [Roll Forward]
Beginning balance	9
Charges	3
Non-cash asset impairment	0
Cash payments	(6)
Ending balance	6		9
Facility Exit Costs [Member]
Restructuring Accrual [Roll Forward]
Beginning balance	4
Charges	1
Non-cash asset impairment	0
Cash payments	(1)
Ending balance	4		4
Non-Cash Impairment Charges [Member]
Restructuring Accrual [Roll Forward]
Beginning balance	0
Charges	7
Non-cash asset impairment	(7)
Cash payments	0
Ending balance	$ 0		$ 0

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities, Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Millions	Dec. 29, 2018	Sep. 29, 2018
Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities [Abstract]
Employee compensation	$ 106	$ 113
Accrued taxes	79	72
Rebates	64	58
Interest	43	49
Tax receivable agreement obligation	12	16
Restructuring	10	13
Accrued operating expenses	113	95
Accrued expenses and other current liabilities	$ 427	$ 416

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities, Other Long-Term Liabilities (Details) - USD ($) $ in Millions	Dec. 29, 2018	Sep. 29, 2018
Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities [Abstract]
Uncertain tax positions	$ 68	$ 67
Deferred purchase price	43	40
Pension liability	42	45
Lease retirement obligation	40	39
Sale-lease back deferred gain	21	21
Transition tax	18	18
Derivative instruments	13	12
Tax receivable agreement obligation	12	23
Other	24	24
Other long-term liabilities	$ 281	$ 289

Long-Term Debt, Summary of Long-Term Debt (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 29, 2018	Sep. 29, 2018
Long-term Debt [Abstract]
Debt discounts and deferred fees	$ (40)	$ (43)
Capital leases and other	125	135
Total long-term debt	5,737	5,844
Current portion of long-term debt	(37)	(38)
Long-term debt, less current portion	5,700	5,806
Term Loan due February 2020 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 700	800
Maturity date	Feb. 29, 2020
Term Loan due January 2021 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 814	814
Maturity date	Jan. 31, 2021
Term Loan due October 2022 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 1,545	1,545
Maturity date	Oct. 31, 2022
Term Loan due January 2024 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 493	493
Maturity date	Jan. 31, 2024
Revolving Line of Credit [Member]
Long-term Debt [Abstract]
Long-term debt	$ 0	0
Maturity date	May 31, 2020
5 1/2% Second Priority Senior Secured Notes due May 2022 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 500	500
Interest rate	5.50%
Maturity date	May 31, 2022
6% Second Priority Senior Secured Notes due October 2022 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 400	400
Interest rate	6.00%
Maturity date	Oct. 31, 2022
5 1/8% Second Priority Senior Secured Notes due July 2023 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 700	700
Interest rate	5.125%
Maturity date	Jul. 31, 2023
4 1/2% Second Priority Senior Secured Notes due February 2026 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 500	$ 500
Interest rate	4.50%
Maturity date	Feb. 28, 2026

Long-Term Debt, Term Loans (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 29, 2018	Dec. 30, 2017
Long-Term Debt [Abstract]
Repayment of long-term borrowings	$ 110	$ 108
Term Loan due February 2020 [Member] \| LIBOR [Member]
Long-Term Debt [Abstract]
Basis spread on variable rate	1.75%
Term Loan due January 2021 [Member] \| LIBOR [Member]
Long-Term Debt [Abstract]
Basis spread on variable rate	1.75%
Term Loan due October 2022 [Member] \| LIBOR [Member]
Long-Term Debt [Abstract]
Basis spread on variable rate	2.00%
Term Loan due January 2024 [Member] \| LIBOR [Member]
Long-Term Debt [Abstract]
Basis spread on variable rate	2.00%

Financial Instruments and Fair Value Measurements, Cross-Currency and Interest Rate Swaps (Details) € in Millions, $ in Millions	3 Months Ended
	Dec. 29, 2018 USD ($)	Dec. 29, 2018 EUR (€)
Cross-Currency Swaps [Member]
Cross-Currency and Interest Rate Swaps [Abstract]
Notional amount of swap \| €		€ 250
Interest Rate Swap - May 2017 [Member]
Cross-Currency and Interest Rate Swaps [Abstract]
Notional amount of swap	$ 450
Fixed annual rate of swap	2.00%	2.00%
Interest Rate Swap - May 2017 [Member] \| LIBOR [Member]
Cross-Currency and Interest Rate Swaps [Abstract]
Term of variable rate	1 month
Interest Rate Swap - June 2018 [Member]
Cross-Currency and Interest Rate Swaps [Abstract]
Notional amount of swap	$ 1,000
Fixed annual rate of swap	2.808%	2.808%
Interest Rate Swap - June 2018 [Member] \| LIBOR [Member]
Cross-Currency and Interest Rate Swaps [Abstract]
Term of variable rate	1 month

Financial Instruments and Fair Value Measurements, Fair Value of Derivative and Location on Consolidated Balance Sheets (Details) - USD ($) $ in Millions	Dec. 29, 2018	Sep. 29, 2018
Cross-Currency Swaps [Member] \| Designated [Member] \| Other Long-Term Liabilities [Member]
Derivative Instruments [Abstract]
Fair value of derivative instruments	$ 3	$ 11
Interest Rate Swaps [Member] \| Designated [Member] \| Other Assets [Member]
Derivative Instruments [Abstract]
Fair value of derivative instruments	7	16
Interest Rate Swaps [Member] \| Designated [Member] \| Other Long-Term Liabilities [Member]
Derivative Instruments [Abstract]
Fair value of derivative instruments	10	0
Interest Rate Swaps [Member] \| Not Designated [Member] \| Other Long-Term Liabilities [Member]
Derivative Instruments [Abstract]
Fair value of derivative instruments	$ 0	$ 1

Financial Instruments and Fair Value Measurements, Effect of Derivatives on Consolidated Statements of Operations (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 29, 2018	Dec. 30, 2017
Derivative Instruments [Abstract]
Amortization related to unrealized losses in Accumulated other comprehensive loss for next 12 months	$ 9
Foreign Currency Swaps [Member] \| Other (Income) Expense, Net [Member]
Derivative Instruments [Abstract]
Loss (gain) on derivative instruments	(4)	$ 2
Interest Rate Swaps [Member] \| Interest Expense, Net [Member]
Derivative Instruments [Abstract]
Loss (gain) on derivative instruments	$ (2)	$ (1)

Financial Instruments and Fair Value Measurements, Assets Measured at Fair Value on Non-Recurring Basis (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Dec. 29, 2018	Sep. 29, 2018
Impairment [Abstract]
Indefinite-lived trademarks	$ 0	$ 0
Goodwill	0	0
Definite lived intangible assets	0	0
Property, plant, and equipment	7	0
Impairment charges	7	0
Fair Value Adjustment [Abstract]
Fair value of long-term indebtedness in excess of book value	45
Fair Value on Nonrecurring Basis [Member]
Fair Value of Assets [Abstract]
Indefinite-lived trademarks	248	248
Goodwill	2,941	2,944
Definite lived intangible assets	1,054	1,092
Property, plant, and equipment	2,457	2,488
Total	6,700	6,772
Fair Value on Nonrecurring Basis [Member] \| Level 1 [Member]
Fair Value of Assets [Abstract]
Indefinite-lived trademarks	0	0
Goodwill	0	0
Definite lived intangible assets	0	0
Property, plant, and equipment	0	0
Total	0	0
Fair Value on Nonrecurring Basis [Member] \| Level 2 [Member]
Fair Value of Assets [Abstract]
Indefinite-lived trademarks	0	0
Goodwill	0	0
Definite lived intangible assets	0	0
Property, plant, and equipment	0	0
Total	0	0
Fair Value on Nonrecurring Basis [Member] \| Level 3 [Member]
Fair Value of Assets [Abstract]
Indefinite-lived trademarks	248	248
Goodwill	2,941	2,944
Definite lived intangible assets	1,054	1,092
Property, plant, and equipment	2,457	2,488
Total	$ 6,700	$ 6,772

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended
Income Taxes (Details) - USD ($) $ in Millions	Dec. 29, 2018	Dec. 30, 2017
Income Taxes [Abstract]
Transition tax benefit		$ (95)
Effective tax rate	21.00%
Share-based compensation excess tax benefit	(2.00%)
Research and development credits	(1.00%)
U.S. state income taxes	4.00%

Operating Segments, Selected Information by Reportable Segment (Details) $ in Millions	3 Months Ended
	Dec. 29, 2018 USD ($) Segment	Dec. 30, 2017 USD ($)	Sep. 29, 2018 USD ($)
Selected Information by Reportable Segment [Abstract]
Number of reportable segments \| Segment	3
Net sales	$ 1,972	$ 1,776
Operating income	176	163
Depreciation and amortization	138	129
Total assets	8,972		$ 9,131
Total goodwill	2,941		2,944
Operating Segment [Member] \| Engineered Materials [Member]
Selected Information by Reportable Segment [Abstract]
Net sales	669	648
Operating income	94	88
Depreciation and amortization	31	29
Total assets	1,964		1,998
Total goodwill	630		633
Operating Segment [Member] \| Health, Hygiene & Specialties [Member]
Selected Information by Reportable Segment [Abstract]
Net sales	702	577
Operating income	49	37
Depreciation and amortization	54	46
Total assets	3,811		3,913
Total goodwill	903		902
Operating Segment [Member] \| Consumer Packaging [Member]
Selected Information by Reportable Segment [Abstract]
Net sales	601	551
Operating income	33	38
Depreciation and amortization	53	$ 54
Total assets	3,197		3,220
Total goodwill	$ 1,408		$ 1,409

Operating Segments, Selected Information by Geography (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 29, 2018	Dec. 30, 2017	Sep. 29, 2018
Selected Information by Geography [Abstract]
Net sales	$ 1,972	$ 1,776
Long-lived assets	6,766		$ 6,846
Reportable Geography [Member] \| North America [Member]
Selected Information by Geography [Abstract]
Net sales	1,605	1,466
Long-lived assets	5,685		5,764
Reportable Geography [Member] \| South America [Member]
Selected Information by Geography [Abstract]
Net sales	96	74
Long-lived assets	332		320
Reportable Geography [Member] \| Europe [Member]
Selected Information by Geography [Abstract]
Net sales	204	170
Long-lived assets	451		463
Reportable Geography [Member] \| Asia [Member]
Selected Information by Geography [Abstract]
Net sales	67	$ 66
Long-lived assets	$ 298		$ 299

Operating Segments, Selected Information by Product Line (Details) - Net Sales [Member]	3 Months Ended
	Dec. 29, 2018	Dec. 30, 2017
Engineered Materials [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	100.00%	100.00%
Engineered Materials [Member] \| Performance Materials [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	39.00%	43.00%
Engineered Materials [Member] \| Engineered Products [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	61.00%	57.00%
Health, Hygiene & Specialties [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	100.00%	100.00%
Health, Hygiene & Specialties [Member] \| Health [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	18.00%	19.00%
Health, Hygiene & Specialties [Member] \| Hygiene [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	52.00%	44.00%
Health, Hygiene & Specialties [Member] \| Specialties [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	30.00%	37.00%
Consumer Packaging [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	100.00%	100.00%
Consumer Packaging [Member] \| Rigid Open Top [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	44.00%	43.00%
Consumer Packaging [Member] \| Rigid Closed Top [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	56.00%	57.00%

Share Repurchase Program (Details) - USD ($) shares in Thousands, $ in Millions	3 Months Ended
	Dec. 29, 2018	Sep. 29, 2018
Share Repurchase Program [Abstract]
Authorized amount of share repurchase program		$ 500
Number of shares repurchased and retired (in shares)	1,132
Shares repurchased and retired	$ 54
Remaining amount of share repurchase program	$ 412

Basic and Diluted Net Income Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended
	Dec. 29, 2018	Dec. 30, 2017
Basic and Diluted Net Income Per Share [Abstract]
Antidilutive shares excluded from computation of earnings per share (in shares)	3.0
Numerator [Abstract]
Consolidated net income	$ 88	$ 163
Denominator [Abstract]
Weighted average common shares outstanding - basic (in shares)	131.1	131.0
Dilutive shares (in shares)	2.7	5.0
Weighted average common and common equivalent shares outstanding - diluted (in shares)	133.8	136.0
Per Common Share Income [Abstract]
Basic (in dollars per share)	$ 0.67	$ 1.24
Diluted (in dollars per share)	$ 0.66	$ 1.20

Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 29, 2018	Dec. 30, 2017
Accumulated Other Comprehensive Loss [Roll Forward]
Other comprehensive income (loss) before reclassifications	$ (26)	$ (11)
Net amount reclassified from accumulated other comprehensive income (loss)	(2)	3
Provision for income taxes	7	(4)
Accumulated Other Comprehensive Loss [Member]
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance	(156)	(68)
Ending balance	(177)	(80)
Currency Translation [Member]
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance	(175)	(48)
Other comprehensive income (loss) before reclassifications	(4)	(24)
Net amount reclassified from accumulated other comprehensive income (loss)	0	0
Provision for income taxes	0	0
Ending balance	(179)	(72)
Defined Benefit Pension and Retiree Health Benefit Plans [Member]
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance	(13)	(16)
Other comprehensive income (loss) before reclassifications	0	(1)
Net amount reclassified from accumulated other comprehensive income (loss)	0	0
Provision for income taxes	0	0
Ending balance	(13)	(17)
Interest Rate Swaps [Member]
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance	32	(4)
Other comprehensive income (loss) before reclassifications	(22)	14
Net amount reclassified from accumulated other comprehensive income (loss)	(2)	3
Provision for income taxes	7	(4)
Ending balance	$ 15	$ 9

Guarantor and Non-Guarantor Financial Information, Condensed Supplemental Consolidated Statements of Income (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 29, 2018	Dec. 30, 2017
Guarantor and Non-Guarantor Financial Information [Abstract]
Percentage ownership in guarantor subsidiaries	100.00%
Condensed Supplemental Consolidated Statements of Operations [Abstract]
Net sales	$ 1,972	$ 1,776
Cost of goods sold	1,619	1,447
Selling, general and administrative	124	117
Amortization of intangibles	42	38
Restructuring and impairment charges	11	11
Operating income	176	163
Other expense (income), net	0	9
Interest expense, net	64	62
Equity in net income of subsidiaries	0	0
Income before income taxes	112	92
Income tax expense	24	(71)
Net income	88	163
Comprehensive net income	67	151
Eliminations [Member]
Condensed Supplemental Consolidated Statements of Operations [Abstract]
Net sales	0	0
Cost of goods sold	0	0
Selling, general and administrative	0	0
Amortization of intangibles	0	0
Restructuring and impairment charges	0	0
Operating income	0	0
Other expense (income), net	0	0
Interest expense, net	0	0
Equity in net income of subsidiaries	179	164
Income before income taxes	(179)	(164)
Income tax expense	(24)	71
Net income	(155)	(235)
Comprehensive net income	(155)	(235)
Parent [Member]
Condensed Supplemental Consolidated Statements of Operations [Abstract]
Net sales	0	0
Cost of goods sold	0	0
Selling, general and administrative	0	0
Amortization of intangibles	0	0
Restructuring and impairment charges	0	0
Operating income	0	0
Other expense (income), net	0	0
Interest expense, net	0	0
Equity in net income of subsidiaries	(112)	(92)
Income before income taxes	112	92
Income tax expense	24	(71)
Net income	88	163
Comprehensive net income	88	163
Issuer [Member]
Condensed Supplemental Consolidated Statements of Operations [Abstract]
Net sales	141	138
Cost of goods sold	85	106
Selling, general and administrative	13	12
Amortization of intangibles	0	0
Restructuring and impairment charges	0	0
Operating income	43	20
Other expense (income), net	1	5
Interest expense, net	5	5
Equity in net income of subsidiaries	(67)	(72)
Income before income taxes	104	82
Income tax expense	16	(81)
Net income	88	163
Comprehensive net income	79	160
Guarantor Subsidiaries [Member]
Condensed Supplemental Consolidated Statements of Operations [Abstract]
Net sales	1,377	1,225
Cost of goods sold	1,142	989
Selling, general and administrative	87	80
Amortization of intangibles	36	31
Restructuring and impairment charges	7	7
Operating income	105	118
Other expense (income), net	1	7
Interest expense, net	45	43
Equity in net income of subsidiaries	0	0
Income before income taxes	59	68
Income tax expense	0	0
Net income	59	68
Comprehensive net income	59	68
Non-Guarantor Subsidiaries [Member]
Condensed Supplemental Consolidated Statements of Operations [Abstract]
Net sales	454	413
Cost of goods sold	392	352
Selling, general and administrative	24	25
Amortization of intangibles	6	7
Restructuring and impairment charges	4	4
Operating income	28	25
Other expense (income), net	(2)	(3)
Interest expense, net	14	14
Equity in net income of subsidiaries	0	0
Income before income taxes	16	14
Income tax expense	8	10
Net income	8	4
Comprehensive net income	$ (4)	$ (5)

Guarantor and Non-Guarantor Financial Information, Condensed Supplemental Consolidated Balance Sheet (Details) - USD ($) $ in Millions	Dec. 29, 2018	Sep. 29, 2018	Dec. 30, 2017	Sep. 30, 2017
Assets [Abstract]
Current assets	$ 2,206	$ 2,285
Intercompany receivable	0	0
Property, plant and equipment, net	2,457	2,488
Other assets	4,309	4,358
Total assets	8,972	9,131
Liabilities and Stockholders' Equity [Abstract]
Current liabilities	1,179	1,237
Intercompany payable	0	0
Other long-term liabilities	6,338	6,460
Stockholders' equity	1,455	1,434	$ 1,174	$ 1,015
Total liabilities and stockholders' equity	8,972	9,131
Eliminations [Member]
Assets [Abstract]
Current assets	0	0
Intercompany receivable	(2,154)	(2,252)
Property, plant and equipment, net	0	0
Other assets	(8,904)	(8,769)
Total assets	(11,058)	(11,021)
Liabilities and Stockholders' Equity [Abstract]
Current liabilities	0	0
Intercompany payable	(2,154)	(2,252)
Other long-term liabilities	0	0
Stockholders' equity	(8,904)	(8,769)
Total liabilities and stockholders' equity	(11,058)	(11,021)
Parent [Member]
Assets [Abstract]
Current assets	0	0
Intercompany receivable	248	296
Property, plant and equipment, net	0	0
Other assets	1,593	1,544
Total assets	1,841	1,840
Liabilities and Stockholders' Equity [Abstract]
Current liabilities	18	18
Intercompany payable	0	0
Other long-term liabilities	368	388
Stockholders' equity	1,455	1,434
Total liabilities and stockholders' equity	1,841	1,840
Issuer [Member]
Assets [Abstract]
Current assets	214	249
Intercompany receivable	1,878	1,907
Property, plant and equipment, net	79	79
Other assets	6,326	6,247
Total assets	8,497	8,482
Liabilities and Stockholders' Equity [Abstract]
Current liabilities	248	218
Intercompany payable	0	0
Other long-term liabilities	5,851	5,945
Stockholders' equity	2,398	2,319
Total liabilities and stockholders' equity	8,497	8,482
Guarantor Subsidiaries [Member]
Assets [Abstract]
Current assets	1,243	1,240
Intercompany receivable	0	0
Property, plant and equipment, net	1,660	1,684
Other assets	4,808	4,849
Total assets	7,711	7,773
Liabilities and Stockholders' Equity [Abstract]
Current liabilities	621	635
Intercompany payable	2,154	2,252
Other long-term liabilities	58	68
Stockholders' equity	4,878	4,818
Total liabilities and stockholders' equity	7,711	7,773
Non-Guarantor Subsidiaries [Member]
Assets [Abstract]
Current assets	749	796
Intercompany receivable	28	49
Property, plant and equipment, net	718	725
Other assets	486	487
Total assets	1,981	2,057
Liabilities and Stockholders' Equity [Abstract]
Current liabilities	292	366
Intercompany payable	0	0
Other long-term liabilities	61	59
Stockholders' equity	1,628	1,632
Total liabilities and stockholders' equity	$ 1,981	$ 2,057

Guarantor and Non-Guarantor Financial Information, Condensed Supplemental Consolidated Statements of Cash Flows (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 29, 2018	Dec. 30, 2017
Consolidating Statement of Cash Flows [Abstract]
Cash flow from operating activities	$ 161	$ 153
Cash Flow from Investing Activities [Abstract]
Additions to property, plant and equipment	(75)	(94)
Proceeds from sale of assets	0	3
(Contributions) distributions to/from subsidiaries	0	0
Intercompany advances (repayments)	0	0
Other investing activities, net		0
Net cash from investing activities	(75)	(91)
Cash Flow from Financing Activities [Abstract]
Repayments on long-term borrowings	(110)	(108)
Proceeds from issuance of common stock	5	4
Repurchase of common stock	(52)	0
Payment of tax receivable agreement	(16)	(37)
Changes in intercompany balances	0	0
Net cash from financing activities	(173)	(141)
Effect of exchange rate changes on cash	(1)	1
Net change in cash	(88)	(78)
Cash and cash equivalents at beginning of period	381	306
Cash and cash equivalents at end of period	293	228
Eliminations [Member]
Consolidating Statement of Cash Flows [Abstract]
Cash flow from operating activities	0	0
Cash Flow from Investing Activities [Abstract]
Additions to property, plant and equipment	0	0
Proceeds from sale of assets	0	0
(Contributions) distributions to/from subsidiaries	0	0
Intercompany advances (repayments)	(38)	(69)
Other investing activities, net		0
Net cash from investing activities	(38)	(69)
Cash Flow from Financing Activities [Abstract]
Repayments on long-term borrowings	0	0
Proceeds from issuance of common stock	0	0
Repurchase of common stock	0
Payment of tax receivable agreement	0	0
Changes in intercompany balances	38	69
Net cash from financing activities	38	69
Effect of exchange rate changes on cash	0	0
Net change in cash	0	0
Cash and cash equivalents at beginning of period	0	0
Cash and cash equivalents at end of period	0	0
Parent [Member]
Consolidating Statement of Cash Flows [Abstract]
Cash flow from operating activities	0	0
Cash Flow from Investing Activities [Abstract]
Additions to property, plant and equipment	0	0
Proceeds from sale of assets	0	0
(Contributions) distributions to/from subsidiaries	47	(4)
Intercompany advances (repayments)	0	0
Other investing activities, net		0
Net cash from investing activities	47	(4)
Cash Flow from Financing Activities [Abstract]
Repayments on long-term borrowings	0	0
Proceeds from issuance of common stock	5	4
Repurchase of common stock	(52)
Payment of tax receivable agreement	(16)	(37)
Changes in intercompany balances	16	37
Net cash from financing activities	(47)	4
Effect of exchange rate changes on cash	0	0
Net change in cash	0	0
Cash and cash equivalents at beginning of period	0	0
Cash and cash equivalents at end of period	0	0
Issuer [Member]
Consolidating Statement of Cash Flows [Abstract]
Cash flow from operating activities	55	35
Cash Flow from Investing Activities [Abstract]
Additions to property, plant and equipment	0	(3)
Proceeds from sale of assets	0	0
(Contributions) distributions to/from subsidiaries	(47)	4
Intercompany advances (repayments)	38	69
Other investing activities, net		0
Net cash from investing activities	(9)	70
Cash Flow from Financing Activities [Abstract]
Repayments on long-term borrowings	(108)	(106)
Proceeds from issuance of common stock	0	0
Repurchase of common stock	0
Payment of tax receivable agreement	0	0
Changes in intercompany balances	0	0
Net cash from financing activities	(108)	(106)
Effect of exchange rate changes on cash	0	0
Net change in cash	(62)	(1)
Cash and cash equivalents at beginning of period	133	18
Cash and cash equivalents at end of period	71	17
Guarantor Subsidiaries [Member]
Consolidating Statement of Cash Flows [Abstract]
Cash flow from operating activities	155	139
Cash Flow from Investing Activities [Abstract]
Additions to property, plant and equipment	(59)	(61)
Proceeds from sale of assets	0	0
(Contributions) distributions to/from subsidiaries	0	0
Intercompany advances (repayments)	0	0
Other investing activities, net		0
Net cash from investing activities	(59)	(61)
Cash Flow from Financing Activities [Abstract]
Repayments on long-term borrowings	(2)	(2)
Proceeds from issuance of common stock	0	0
Repurchase of common stock	0
Payment of tax receivable agreement	0	0
Changes in intercompany balances	(93)	(86)
Net cash from financing activities	(95)	(88)
Effect of exchange rate changes on cash	0	0
Net change in cash	1	(10)
Cash and cash equivalents at beginning of period	4	12
Cash and cash equivalents at end of period	5	2
Non-Guarantor Subsidiaries [Member]
Consolidating Statement of Cash Flows [Abstract]
Cash flow from operating activities	(49)	(21)
Cash Flow from Investing Activities [Abstract]
Additions to property, plant and equipment	(16)	(30)
Proceeds from sale of assets	0	3
(Contributions) distributions to/from subsidiaries	0	0
Intercompany advances (repayments)	0	0
Other investing activities, net		0
Net cash from investing activities	(16)	(27)
Cash Flow from Financing Activities [Abstract]
Repayments on long-term borrowings	0	0
Proceeds from issuance of common stock	0	0
Repurchase of common stock	0
Payment of tax receivable agreement	0	0
Changes in intercompany balances	39	(20)
Net cash from financing activities	39	(20)
Effect of exchange rate changes on cash	(1)	1
Net change in cash	(27)	(67)
Cash and cash equivalents at beginning of period	244	276
Cash and cash equivalents at end of period	$ 217	$ 209